Form 4: Cartesian Therapeutics Director Gifts 6,555 Shares

Michael Singer, a Director at Cartesian Therapeutics, Inc., reported gifting 6,555 shares of common stock on March 13, 2026.

Summary

• Michael Singer, a Director of Cartesian Therapeutics, Inc. (RNAC), reported a transaction on March 13, 2026.
• The transaction involved the disposition of 6,555 shares of common stock as a gift (Transaction Code 'G').
• The shares were disposed of at a price of $0 per share, consistent with a gift.
• Following this transaction, Michael Singer directly beneficially owns 49,578 shares of common stock.
• Additionally, Michael Singer indirectly beneficially owns 654,868 shares through various trusts, a spouse, and custodial accounts for children.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. A gift transaction is a routine insider disclosure and does not typically signal a change in company fundamentals or management confidence, unlike a significant open market sale.

Negatives

• The direct beneficial ownership of Michael Singer decreased by 6,555 shares due to the gift transaction.

Industry Context

StockSavvy.ai notes that insider gift transactions, while reducing direct ownership, are typically part of personal financial or estate planning and do not usually reflect a change in the insider's operational outlook for the company, unlike open market sales.

Related Party Transactions

• Indirect beneficial ownership includes shares held in trusts for the benefit of the reporting person's spouse and children, by the reporting person's spouse, and in custodial accounts for the reporting person's children.

Stakeholder Impact

• Shareholders: Minimal direct impact from a gift transaction, as it does not involve a market sale that would affect liquidity or price directly.

Key Dates

Keywords

Cartesian Therapeutics, RNAC, Michael Singer, Insider Transaction, Form 4, Stock Gift, Director Holdings